Hamostaseologie

Papers
(The TQCC of Hamostaseologie is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig64
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity37
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)31
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism21
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien19
19
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung18
Asundexian and milvexian: Pharmacodynamic insights from coagulation assays17
A novel assay to quantify extrinsic tenase complexes in body fluids17
Tolerance Breakdown in Hemophilia A Mice is Orchestrated by Bacterial Infection Modulating Antigen-Specific B and T cell Responses16
Mitteilungen aus der Vorstandsarbeit16
ITAM upregulation in platelets after major surgery16
Platelet activating histone/anti-histone immune complexes are associated with a new entity of thrombosis and thrombocytopenia syndrome16
14
Hemophilia care from pediatrics to adulthood – a model of joint interdisciplinary guided transition at a Hemophilia Comprehensive Care Center (HCCC)12
Assessing the impact of a pulmonary embolism response team on patients presenting with intermediate risk acute pulmonary embolism. A prospective study (ongoing)11
Elevated von Willebrand factor levels during anticoagulation predict early recurrence of venous thromboembolism11
Long-term management of deep vein thrombosis based on medical history - A prospective cohort analysis11
Gabapentin and pregabalin can be associated with clinically relevant bleeding due to disturbed platelet function – Two case reports10
Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?10
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience8
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment8
7
Komplementdysregulation als Biomarker für Post Covid7
Subsegmental Pulmonary Embolism7
Sulodexid: Neue Hoffnung bei retinalen Gefäßerkrankungen7
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India7
A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease7
Platelets in Myocardial Ischemia/Reperfusion Injury7
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert7
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future7
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)6
Increased transfusion requirement in children compared to adults undergoing cardiac surgery6
Pregnancy complications in female haemophilia patients and carriers of haemophilia A and B- a nationwide survey6
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia6
Autoantibody-induced platelet Fc-gamma-RIIA-mediated procoagulant platelets are important drivers of immunothrombosis in antiphospholipid syndrome6
Results of an international survey (ISTH) on the management of therapeutic-intensity unfractionated heparin6
Management of Hemophilia C (Factor XI Deficiency) in Two Families: A Case Study at the University Hospital of Halle (Saale)6
Efficacy of Rivaroxaban in Children with Short Bowel Syndrome6
Targeting antigen-specific B cells in immune mediated thrombotic thrombocytopenic purpura using modular CAR T cells6
Erratum: A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia5
Evidence in Haemophilia Assessment: The Haemophilia Joint Health Score5
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers5
GTH News5
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion5
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment5
Management of Antithrombin Deficiency in Pregnancy5
Reference Intervals in Coagulation Analysis5
Enhanced platelet turnover after acute myocardial infarction in thrombocytopenic mice and GPVI-deficient mice5
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland4
Venous Thrombosis and SARS-CoV-24
The Impact of non-factor VIII therapy in haemophilia A on procoagulant platelets4
Correlation between Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio and Burden of Thrombus with Disease Severity in Patients with Pulmonary Thromboembolism4
Platelets and COVID-194
Influence of coagulation proteases on cognitive function4
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits4
Hypofibrinolytic dysregulations can be detected of frozen plasma samples using viscoelastic testing4
Recurrent Venous Thrombosis in a Hypofibrinogenemic Patient Despite a Heterozygous Deletion of the Fibrinogen Gene Cluster and Hemizygous FGB p.Pro265Leu Variant Mimicking a Homozygous Genotype3
Recognizing inherited platelet disorders on the peripheral blood smear by immunofluorescence microscopy: results of the first international workshop3
Veranstaltung des BDDH im Rahmen der 67. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Frankfurt3
Familial Protein S deficiency with severe venous thromboembolism (VTE)3
GTH News3
Communication in Healthcare: Global challenges in the 21st Century3
Endothelial Mechanisms Modulate the Prothrombotic Phenotype of Factor V Leiden Carriers: Evidence from an Ex Vivo Model3
Treatment of Inherited Platelet Disorders: Current Status and Future Options3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS13
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis3
Echtzeit-Bildgebung der durch Blutplättchen induzierten Blutgerinnselbildung und -auflösung zeigt unterschiedliche Auswirkungen von Antikoagulantien3
Update des Versorgungsvertrages nach § 132 i SGBV3
The Use of Large Animal Models in Trauma and Bleeding Studies3
Bleeding Risk in Patients with Cancer3
A patient with Klippel-Trénaunay-Syndrom and cerebral venous sinus thrombosis3
Acquired von Willebrand Syndrome in Children3
Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors3
Development and evaluation of a novel machine learning algorithm for outpatient thrombophilia diagnosis, management, and venous thrombosis risk stratification3
Neuigkeiten zur Ablösung der geplanten Ablösung der In-Vitro-Diagnostika-Richtlinie durch die In-Vitro-Diagnostika-Verordnung (IVDR) 05/2022 und Plasmaversorgung in Deutschland/EU und Fortführung der 3
3
Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders3
Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021—Data from the Kompetenznetz Hämorrhagische Diathese Ost (KHDO)3
Role of Tissue Transglutaminase 2 in Fibrin Formation and Haemostasis3
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories3
Gleiches Risiko für schwere kardiovaskuläre Ereignisse nach hämorrhagischem und ischämischem Schlaganfall3
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence2
Haemostaseological pearls2
Investigating the impact of oligogenic variation on severity of bleeding in hypofibrinogenemia2
Treatment of Atypical Clots2
Stable Factor IX Expression and Sustained Reductions in Factor IX Use 8 Years After Gene Therapy With CSL220 (Formerly AMT-060) in Adults with Hemophilia B [ENCORE]2
Venous Thromboembolism Issues in Women2
GTH News2
A Review of FXIa Inhibition as a Novel Target for Anticoagulation2
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko2
Determination of thrombotic risk in patients with antiphospholipid syndrome using a modified thrombin generation assay2
The Great Return: Rebuilding and Advancing the Swiss Haemophilia Registry2
Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia®) Activity Using Reagent-/Platform-Specific Conversion Factors2
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations2
In Japan 40% Blutungskomplikationen während ECMO-Therapie bei COVID-192
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei2
2
Identification of novel cryptic epitopes uncovers a distinct and consistent open ADAMTS13 conformation in iTTP2
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives2
Recombinant factor VIII binding to platelets influences fibrin clot formation and stability2
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline2
Leichte Schlaganfälle: Thrombolyse und routinemäßige medi-zinische Versorgung im Vergleich1
From Code to Clots: Applying Machine Learning to Clinical Aspects of Venous Thromboembolism Prevention, Diagnosis, and Management1
NBEAL2 related Gray Platelet Syndrome with a combined platelet granules secretion defect in flow cytometry1
Managing immune thrombocytopenia (ITP) during pregnancy- Single centre 15 years experience at a tertiary care institute1
Clot-Wave-Analyse könnte individualisierte Therapie bei Hämophilie A verbessern1
Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL1
The evidence of enlarged platelets with reduced expression of glycoprotein Ib/IX might indicate recessive inherited thrombocytopenias other than Bernard-Soulier Syndrome1
Evaluating the prevalence and profile of antibodies against Polyethylene Glycol in hemophilia patients and healthy Individuals1
Advancing Treatment Options: Two Phase 3 Studies Investigating the Efficacy, Safety, and Pharmacokinetics of an Antithrombin Concentrate in Patients with Congenital and Acquired Antithrombin Deficienc1
First Interim Analysis of Clinical Outcomes in Adults and Adolescents With Severe Hemophilia A Receiving Efanesoctocog Alfa Prophylaxis in XTEND-ed, a Phase 3 Long-term Extension Study1
Microvascular Skin Manifestations Caused by COVID-191
Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis1
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice1
vWF/GPIb mechano-dependent interactions require F-actin disassembly by the oxidoreductase MICAL11
Noncanonical Regulation of ACKR3/CXCR7 on Lipid Mediators in Immunothrombotic Platelet Response following FcγRIIa Stimulation1
Treatment Burden during a Phase 3 Randomized, Crossover Study of Recombinant ADAMTS13 Prophylaxis and Standard of Care in Patients with Congenital Thrombotic Thrombocytopenic Purpura1
Erhöhte Faktor-VIII-Aktivität – gesteigertes Risiko für Pfortaderthrombosen1
Post Partum Haemorrhage: prepartum plasmin and thrombin generation is similar in women with and without PPH1
Reform des Kapitels 32 (Laboratoriumsmedizin) im einheitlichen Bewertungsmaßstab (EBM)1
Promoting young talents - “Coagulation for bloody beginners” („Gerinnung für blutige Anfänger*innen“)1
Novel Perspectives on Thrombopoietin Receptor Agonists Applications1
Association Between Major Bleeding and In-Hospital Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes1
Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis1
GTH News1
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren1
1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events1
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report1
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology1
Glycoprotein-specific antibodies modulates platelet phenotypes in an epitope-dependent manner1
Management of Vascular Thrombosis in Patients with Thrombocytopenia1
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group1
Intensive lifestyle intervention on thrombin generation in individuals at high risk for type 2 diabetes1
Apixaban for thromboprophylaxis in paediatric cardiology patients – Real-world data from a single institution1
The Potential of HMB-001 as a Prophylactic Treatment of Glanzmann Thrombasthenia: Interim Analysis of the Phase 2 Study1
Fibrin exposition on the surface of the remaining part of arterial thrombus arrests the thrombus growth1
Progress in Hemostasis (Part 1): Improved Management of Inherited Platelet Disorders: Reality or Illusion?1
The Role of Platelet microRNAs in Cancer1
Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting1
Animal and Cellular Models in Thrombosis and Hemostasis1
Intravital Imaging of Thrombosis Models in Mice1
Platelet Dysregulation in the Pathobiology of COVID-191
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert1
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis1
Feasibility of a VWF:Ag latex immunoassay on a fully automated coagulation analyzer1
0.10979199409485